Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Digoxin therapy in chronic heart failure

M Gheorghiade¹

¹Division of Cardiology, Northeastern University Medical School, Chicago, IL 60611, USA.

Cardiovascular Drugs and Therapy

|May 1, 1997

Summary

Digoxin improves hemodynamics and reduces heart failure hospitalizations in chronic heart failure patients. However, this digitalis glycoside does not impact long-term survival in patients receiving standard treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Predictive value of dobutamine stress echocardiography for coronary artery disease detection in liver transplant candidates.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2008

Same author

Ultrasound lung comets for the differential diagnosis of acute cardiogenic dyspnoea: a comparison with natriuretic peptides.

European journal of heart failure·2007

Same author

Autologous hematopoietic stem cell transplantation in systemic lupus erythematosus patients with cardiac dysfunction: feasibility and reversibility of ventricular and valvular dysfunction with transplant-induced remission.

Bone marrow transplantation·2007

Same author

Impact of intracoronary aspiration thrombectomy during primary angioplasty on left ventricular remodelling in patients with anterior ST elevation myocardial infarction.

Heart (British Cardiac Society)·2005

Same author

Hematopoietic stem cell transplantation for cardiac and peripheral vascular disease.

Bone marrow transplantation·2003

Same author

Intravenous therapy for chronic heart failure exacerbations.

Congestive heart failure (Greenwich, Conn.)·2002

Area of Science:

Cardiology
Pharmacology

Background:

Digitalis, specifically digoxin, has a long history of use.
Recent research has focused on its role in chronic heart failure (CHF) management.

Purpose of the Study:

To investigate the hemodynamic and clinical effects of digoxin in patients with CHF.
To evaluate the impact of digoxin on survival and hospitalizations in CHF.

Main Methods:

Systematic review and analysis of studies on digoxin in CHF.
Inclusion of data from randomized controlled trials, including the large-scale DIG Trial.

Main Results:

Digoxin improves cardiac output and central hemodynamics, particularly in patients with severe CHF.
Chronic digoxin therapy leads to sustained sympathoinhibitory effects and reduced norepinephrine levels.
Discontinuation of digoxin resulted in hemodynamic deterioration and worsening heart failure symptoms.
The DIG Trial showed no impact on mortality but significantly reduced heart failure hospitalizations.

Conclusions:

Digoxin offers significant hemodynamic benefits and reduces hospitalizations in chronic heart failure.
While not impacting survival, digoxin remains a valuable therapeutic option for managing CHF symptoms and preventing readmissions.

Related Experiment Videos